Veracyte (VCYT) Stock: Buy, Sell, or Hold?

VCYT - Veracyte, Inc.

SERVICES-MEDICAL LABORATORIES
$46.22
1.43 (3.19%) ▲
5d: +6.23%
30d: +6.6%
90d: -20.15%
WAIT
LOW Confidence
Protect Your VCYT Gains
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 04, 2026 12d

Get Alerted When VCYT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
â„šī¸ NEUTRAL: VCYT is fairly priced but lacks strong directional signals. At 0.0% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$53.05
Based on 2.9% avg growth
INTRINSIC VALUE TODAY
$32.94
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.7x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: VCYT is currently trading at $46.22, which is considered fair relative to its 30-day fair value range of $41.22 to $45.81. The stock's valuation (Forward PE: 23.8) is in line with its historical norms (23.7). At these levels, the market is pricing in 0.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, VCYT is in a strong downtrend. The price is approaching resistance at $46.43. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.2% recently.

Market Sentiment: The stock scores a mixed 56/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $58.42 (+26.4%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $41.22 - $45.81
Company Quality Score 50/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 78.1%

Protect Your Profits

Holding VCYT? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (56/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+3.2%)
  • BULLISH: Trading 26.4% below Wall St target ($58.42)
  • NEUTRAL: Market pricing in 0.0% annual earnings growth - fairly valued
  • WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $41.22 - $45.81
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $41.22
Resistance Level $46.43
Current Trend Strong Downtrend
Technical data as of Oct 21, 2026

Fundamental Context

Forward P/E (Next Year Est.) 23.76
Wall Street Target $58.42 (+26.4%)
Revenue Growth (YoY) 15.5%
Earnings Growth (YoY) 288.9%
Profit Margin 20.4%
PE vs Historical 23.8 vs 23.7 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): 0% (market-implied from PE analysis)
1-Year Target $46.22 (0%)
2-Year Target $46.22 (0%)
3-Year Target $46.22 (0%)
3-Yr Target (if PE normalizes) (PE: 24→24) PE COMPRESSION $46.11 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 23.8, Growth: 1.7%) $48.67 (+5%)
Base: (SPY PE: 19.9, Growth: 1.7%) $40.68 (-12%)
Bear: (PE: 16.9, Growth: 1.7%) $34.58 (-25%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (32x PE), but valuation improves significantly next year (24x PE) as earnings recover.
Trailing PE: 31.99 | Current EPS (TTM): $1.40
Bull Case $68.46 (+48%)
Analyst growth 39.0%, PE expands to 35.2
Base Case $62.24 (+35%)
Market implied 39.0%, PE stable at 32.0
Bear Case $30.46 (-34%)
Severe decline -20.0%, PE contracts to 27.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: October 21, 2026 10:01 PM ET
Data refreshes hourly during market hours. Next update: 11:01 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for VCYT.

Create Free Account

Already have an account? Log In

Top Rated Diagnostics & Research Stocks

Top-rated stocks in Diagnostics & Research by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
GH
Guardant Health Inc
STRONG BUY
26 analysts
$202 61 BUY
EXAS
EXACT Sciences Corporatiâ€Ļ
STRONG BUY
26 analysts
$106 52 HOLD
TMO
Thermo Fisher Scientificâ€Ļ
STRONG BUY
28 analysts
$691 42 HOLD
DHR
Danaher Corporation
STRONG BUY
25 analysts
$244 40 SELL
NTRA
Natera Inc
STRONG BUY
23 analysts
$404 44 HOLD

Advanced VCYT Option Strategies

Professional options setups generated by AI based on today's VCYT price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for VCYT

VCYT Technical Chart VCYT Price Prediction VCYT Earnings Date VCYT Investment Advisor VCYT Fair Price Analyzer VCYT Options Advisor VCYT Options Chain VCYT Options Analysis VCYT Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals